Moreover, clinical studies in thyroid cancer, gastrointestinal stromal tumors, and T cell non-Hodgkin's lymphoma/leukemias suggested that CD26 expression was associated with distant metastasis, recurrence after resection, or poor survival [29]–[31]. The gene discussed is DPP4; the disease is leukemia.